scorecardresearch
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
Save 41% with our annual Print + Digital offer of Business Today Magazine
BT-Ernst and Young deal watch

BT-Ernst and Young deal watch

The Orchid Chemicals and Pharmaceuticals and Hospira Inc. deal for the purchase of the former's generic injectable pharmaceuticals business will benefit both parties.

The Orchid Chemicals and Pharmaceuticals and Hospira Inc. deal for the purchase of the former's generic injectable pharmaceuticals business will benefit both parties. While Hospira will gain from Orchid's modern R and D facility, it would strengthen Orchid's business model by providing a steady revenue stream through its long-term API supply agreement with Hospira.

TARGET ACQUIRER/INDUSTRY TYPE DEAL VALUE
(Rs crore)
STAKE (%)
Sistema Shyam Teleservices Russian Federation/ Telecommunications Investment 3,155.2 19.8
DLF Assets Ltd Promoter Group/ Real Estate, Hospitality and Construction Investment 2,328.3 36
Generic Injectable Business of Orchid Chemicals and Pharma Hospira, Inc./ Pharmaceuticals Acquisition 1,868.5 100
Bangalore International Airport GVK Power and Infrastructure/ Infrastructure Investment 686 17
NDTV Imagine Ltd Time Warner Inc./ Media and Entertainment Acquisition 546.3 76
Iron Ore Reserve Mines Pace Textiles Ltd/ Metals and Mining Acquisition 260.3 100
Snowman Frozen Foods Ltd International Finance Corporation/ Retail and Consumer Products Private Equity 248.9 19.99
Aerostaff Australia; Gippsland Aeronautics Mahindra & Mahindra Ltd/ Infrastructure Acquisition 175.1 75.1
Asia Pacific Breweries (Aurangabad) Pvt. Ltd Heineken NV/ Retail & Consumer Products Acquisition 174 100
Siemens Healthcare Siemens India Limited/ Healthcare Acquisition 158.4 100

 

— Ernst and Young is a leading M and A advisor in India. While every care has been taken to compile this data, it is based on media reports, company announcements and other secondary research. Any decision on the basis of the above mentioned information should be taken only after professional advice. Business Today or Ernst and Young do not undertake any responsibility in regard to any such decision.

— This list is not a complete list and includes only M and A, private equity and brand sale transactions

— All deals are the biggest deals in the past 30 days as on December 24, 2009

×